I'm not a scientist and you've admitted it isn't your forte, either. This claim seems rather unsupported.
I do have a mathematics degree, and plenty of mathematics expertise and experience, I feel no qualms about investigating statistical methodology.
There's no "may not" about it, it's very likely a tiny part of their profits. And it isn't billions a year, it's probably less than $1 billion. More below.
I actually clicked on all the links. Probably half were about grants, which I'd consider repetitive. You could have been more focused in your approach, although frankly that may have drawn more attention to the fact that you haven't established any conflict of interest on the Surgeon General's part. (Still haven't see anything on this grant to her you mentioned.) The fact that I'm responding to this three days later tells me I don't have time to spend multiple hours reading all text at those links. Also, it appears you meant to link to a PDF of the foundation's financials in that prior post, but it didn't come through. You probably would have noticed that if you hadn't tossed in so many links in the first place.
Most of them were to grants, a great big many of those grants go directly to foundations doing studies. You can google, if you would like Regina Benjamin 500000 and fellows. You will see quite quickly that she was awarded the McArthur Fellows genius grant for 500K. As mentioned before also a board member of RWJF, which is the single biggest contributor besides the PHARMA lobbying arm to the anti-smoking movement. The study in reference was castigated by many scientists for a lack of any kind of reliable methodology and for containing, no better way to put it blatant lies.
I never said one word about you being bad for smoking. I don't think anyone else did, either. You've also complained about "hate" and "anger" in other posts. Weird that you're trying to play the victim, especially since the only insulting words in this thread were Twain's towards nonsmokers in the essay you posted.

As for saving face, that just made me chuckle.
As I said above, the link to their financials didn't come through.
There has been quite some directed at me, some in this forum, much elsewhere. Smokers have been more denigrated the past 15 years than ever. Though Mark Twain would beg to differ. If people feel insulted by Mark Twain's writing, then I am sure sarcasm and tongue-in-cheek speaking has passed them by. Most people I have read it to, came off with a chuckle. Then, even the non-smokers were those willing to see the bias and angst in society as reflective in the writing, and find the humor within.
You can't even begin to assume that kind of return on investment. Here's why:
1. You have taken my generous sales assumption for JNJ, Pfizer and GSK for smoking-cessation products and assigned them all to JNJ.
I said it was for the industry I believe. J&J does however stand by far the most to gain as virtually all smoking cessation products (except electronic cigs) are produced by them or their subsidiaries. Even with markup, those figures didn't represent Wal-Mart, and the industry is fast approaching a billion/yr. Not surprisingly the more vehement the anti-smoking lobby becomes, and the more regulated things become, the bigger the market segment grows. Now if you spend over 500 million total towards smoking cessation (which has been done), and it is only netting you 200 million a year, (which is way lower than what it is), that is a great investment, especially with looking at potential to rise it every year as you secure the delivery of nicotine further and further into the pharmaceutical market. This isn't some grand conspiracy. You have the people who profit from controlling nicotine, promoting everything they can to increase that control and decrease alternative delivery measures (smoking). Corporations do this all the time, especially in the pharmaceutical industry. Nothing surprising about it.
3. You aren't taking into account the actual cost of making, packaging and distributing the products. I'm confident that the margins on gums and patches pales in comparison to the margins these companies get on prescription drugs.
You are confident? That sounds nice. I am confident the markup on them is immense, and the cost per is unbelievably low. Their other pharmaceuticals surely may be greater though. Sure. Markups on pharmaceuticals are some of the highest markups in existence. It's not surprising when you compare the cost of active ingredients to the end price once it has passed through the corporate markup, then the individual pharmacy markup, most drugs (especially generic) end up over a THOUSAND percentage points marked up on the consumer side. Thank goodness they aren't the car industry. The profit on branded is much less on the retail end, and the profit on branded is greater on the pharmacorp side. Branded tends to not be marked up as much on the retail side, and marked up over twice as much as generic on the pharmacorp side. Most pharmacies would rather dispense generic, however, because they generally make more money with generics.
As far as smoking cessation products moving JNJ's stock, you are basically grasping at straws. Over time, they probably do a tiny bit. That's it. Sheesh, they probably make more money off of Q-tips alone.
I'm not here to defend the actions of drug companies in general--they're far from saintly. Nor have I gone on about the actions of tobacco companies.
I have no illusions that it is moving J&J's stocks in a significant way at all. J&J is huge, massive, unbelievably huge. Smoking cessation is a drop in the bucket, sure, but it is a large drop still. They are in the business of making money, and if they can fund, and exaggerate things to bring in a few hundred extra million with the potential for billions a year (easily), then you can be **** sure they will, and have. You can't see that, not my problem. Downplay all you want, your non-sequitur with q-tips may amuse the unlearned. They make hundreds of millions of dollars off smoking cessation, that may be a drop in the bucket, but it is a large drop, and they love every bit of it, and if you think they won't stoop to unscrupulous means to increase any market segment they can, then I applaud your comfy view of life and the pharmaceutical industry. Whatever it takes to make you happy. (I'm sure they think hundreds of millions are a bigger deal than you think it is).